Biogen (BIIB) Sale Dependent on Value of Aducanumab - BMO Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. USO
6. AWK
7. GNK
8. ARGX
9. FNGR
10. PLUR

Go back to Biogen (BIIB) Sale Dependent on Value of Aducanumab - BMO Capital
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 209.15 -0.68 (0.32%)
Previous Close $209.83    52 Week High $333.65 
Open $208.36    52 Week Low $223.02 
Day High $210.49    P/E 26.78 
Day Low $207.62    EPS $7.81 
Volume 617,104